Inhibition of Chk1 Kinase Sensitizes Leukemia and Lymphoma Cell Lines with TP53 Mutations to Chemotherapy

被引：0
|
作者：
Zemanova, Jana [1 ]
Sebejova, Ludmila [1 ]
Hylse, Ondrej [2 ]
Paruch, Kamil [2 ]
Pavlova, Sarka [1 ]
Mayer, Jiri [3 ,4 ]
Pospisilova, Sarka [1 ]
Trbusek, Martin [1 ]
机构：
[1] Masaryk Univ, Cent European Inst Technol CEITEC, Brno, Czech Republic
[2] St Annes Univ Hosp, Ctr Biomol & Cellular Engn, Int Clin Res Ctr, Brno, Czech Republic
[3] Univ Hosp Brno, Dept Internal Med Hematol & Oncol, Brno, Czech Republic
[4] Masaryk Univ, Fac Med, Brno, Czech Republic
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.2460.2460
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2460
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Clinical significance of TP53 mutations in adult T-cell leukemia/lymphoma
    Sakamoto, Yuma
    Ishida, Takashi
    Masaki, Ayako
    Murase, Takayuki
    Takeshita, Morishige
    Muto, Reiji
    Iwasaki, Hiromi
    Ito, Asahi
    Kusumoto, Shigeru
    Nakano, Nobuaki
    Tokunaga, Masahito
    Yonekura, Kentaro
    Tashiro, Yukie
    Iida, Shinsuke
    Utsunomiya, Atae
    Ueda, Ryuzo
    Inagaki, Hiroshi
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 195 (04) : 571 - 584
  • [2] Inhibition of the checkpoint kinase Chk1 induces DNA damage and cell death in human Leukemia and Lymphoma cells
    Christopher Bryant
    Kirsten Scriven
    Andrew J Massey
    Molecular Cancer, 13
  • [3] Inhibition of the checkpoint kinase Chk1 induces DNA damage and cell death in human Leukemia and Lymphoma cells
    Bryant, Christopher
    Scriven, Kirsten
    Massey, Andrew J.
    MOLECULAR CANCER, 2014, 13
  • [4] A study of combinatorial growth inhibition, cell death and DNA damage repair caused by CHK1 inhibitor SRA737 and WEE1 inhibitor adavosertib in TP53 mutated cell lines.
    Stewart, Adam
    Pickard, Lisa
    Hallsworth, Albert E.
    Sauvaigo, Sylvie
    Muggiolu, Giovanna
    Raynaud, Florence
    Banerji, Udai
    CANCER RESEARCH, 2021, 81 (13)
  • [5] Variety of TP53 Mutations In Russian B-Cell Lymphoma Patients
    Grachev, Alexander
    Gribanova, Elena
    Ryzhko, Vyachelav
    Galtseva, Irina
    Kapranov, Nikolay
    Nakastoev, Islam
    Balzhanova, Yanjima
    Koroleva, Darya
    Shukhov, Oleg
    Julhakyan, Hunan
    Zvonkov, Evgeny
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S390 - S391
  • [6] Variety of TP53 Mutations In Russian B-Cell Lymphoma Patients
    Biderman, Bella
    Severina, Natalya
    Koroleva, Darya
    Gabeeva, Nelli
    Belyaeva, Anastasiya
    Tatarnikova, Svetlana
    Babaeva, Fatima
    Nesterova, Ekaterina
    Mangasarova, Yana
    Margolin, Oleg
    Kravchenko, Sergey
    Obukhova, Tatyana
    Julhakyan, Hunan
    Zvonkov, Evgeny
    Sudarikov, Andrey
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S390 - S390
  • [7] TP53 Gene Mutations in Russian Patients With Mantle Cell Lymphoma (MCL)
    Biderman, Bella
    Koroleva, Darya
    Severina, Natalya
    Gabeeva, Nelly
    Julhakyan, Hunan
    Zvonkov, Evgeniy
    Sudarikov, Andrey
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S460 - S460
  • [8] TP53 MUTATIONS DISRUPTING DNA BINDING LEAD TO CHEMOTHERAPY RESISTANCE IN ACUTE LYMPHOBLASTIC LEUKEMIA
    Pogodzinski, M.
    Yang, F.
    Sun, H.
    Hof, J.
    Eckert, C.
    Zhou, B. -B.
    Kirschner-Schwabe, R.
    HAEMATOLOGICA, 2017, 102 : 27 - 28
  • [9] Combining Ibrutinib with Chk1 Inhibitors Synergistically Targets Mantle Cell Lymphoma Cell Lines
    Restelli, Valentina
    Lupi, Monica
    Vagni, Micaela
    Chila, Rosaria
    Bertoni, Francesco
    Damia, Giovanna
    Carrassa, Laura
    TARGETED ONCOLOGY, 2018, 13 (02) : 235 - 245
  • [10] Combining Ibrutinib with Chk1 Inhibitors Synergistically Targets Mantle Cell Lymphoma Cell Lines
    Valentina Restelli
    Monica Lupi
    Micaela Vagni
    Rosaria Chilà
    Francesco Bertoni
    Giovanna Damia
    Laura Carrassa
    Targeted Oncology, 2018, 13 : 235 - 245
12345